L6 Genetic Risk Assessment for Single Gene Disorders

Educational Objectives & Course Overview

• Course Context:

  • Course: IBSSD 1520 & 1521

  • Module: Module 3, Lecture 6

  • Topic: Genetic Risk Assessment For Single Gene Disorders

  • Instructor: Dr. Susan Viselli

• Terminal Objective:

  • Develop a thorough understanding of the central tenets of modern medical genetics.

• Enabling Objectives:

  • Distinguish phenotypic ratios from genotypic ratios in genetic crosses.

  • Construct and analyze Punnett squares to diagram monohybrid and dihybrid inheritance patterns.

  • Explain the core principles of Mendelian inheritance: the Principle of Segregation and the Principle of Independent Assortment.

  • Apply probability principles, specifically the Multiplication Rule (AND rule) and Addition Rule (OR rule), to genetic pedigree analysis.

  • Utilize the Hardy-Weinberg equilibrium equations to determine allele, genotype, and phenotype frequencies within human populations.

  • Calculate empirical and conditional genetic risk probabilities to solve clinical pedigree questions.

Historical Foundations of Genetics & Mendelian Inheritance

• Johan "Gregor" Mendel (1822–1884):

  • First outlined the foundational laws of formal inheritance through systematic hybridization experiments conducted on garden pea plants (Pisum sativum).

  • Mendel possessed no knowledge of modern concepts such as DNA, chromosomes, or genes, yet his quantitative deductions accurately describe single-gene inheritance.

• Mendelian Inheritance Defined:

  • When the inheritance of a single mutant allele at a specific gene locus produces a consistent clinical or physical trait, it is designated as Mendelian inheritance.

• Mendel's Seven Pea Traits:

  • Each of the seven traits studied by Mendel in Pisum sativum is governed by a single gene located on an autosomal chromosome:

  1. Seed Shape: Round (dominant) vs. Wrinkled (recessive).

  2. Seed Color: Yellow (dominant) vs. Green (recessive).

  3. Seed Coat Color: Gray (dominant) vs. White (recessive).

  4. Pod Shape: Smooth/Inflated (dominant) vs. Constricted (recessive).

  5. Pod Color: Green (dominant) vs. Yellow (recessive).

  6. Flower Position: Axial (dominant) vs. Terminal (recessive).

  7. Plant Height: Tall (dominant) vs. Short/Dwarf (recessive).

Fundamental Laws of Formal Genetics

• Principle of Segregation (Mendel's First Law):

  • Sexually reproducing organisms possess paired genetic factors (alleles) on homologous chromosomes.

  • During gamete formation (meiosis), the two copies of each gene separate so that each gamete receives only one copy/allele.

  • Historical Contrast: Directly refutes the 19th-century "blending theory" of inheritance, which asserted that parental traits blended irreversibly in offspring.

• Principle of Independent Assortment (Mendel's Second Law):

  • Genes residing at different genetic loci assort independently during gamete formation.

  • Caveat & Exception: Independent assortment does not hold when genes are positioned close to one another on the same chromosome, a phenomenon known as genetic linkage.

• Dominant and Recessive Alleles:

  • Alleles: Alternative sequence forms of a specific gene residing at identical autosomal chromosomal loci.

  • Human autosomal chromosomes carry two copies of every gene.

  • Dominant Allele ($A$): The wild-type or standard allele form whose phenotypic expression masks the presence of an alternative allele.

  • Recessive Allele ($a$): An alternative allele form whose phenotype is masked when paired with a dominant allele.

Genotypes, Phenotypes, and Monohybrid Crosses

• Genotype Definitions:

  • Homozygous Dominant ($AA$): Possesses two identical dominant alleles at a locus.

  • Homozygous Recessive ($aa$): Possesses two identical recessive alleles at a locus.

  • Heterozygous ($Aa$): Possesses two non-identical alleles (one dominant, one recessive) at a locus.

• Phenotype Characteristics:

  • Phenotype: The physical, biochemical, or clinical manifestation of a genotype.

  • Genotype-Phenotype Relationship:

  • Two different genotypes ($AA$ and $Aa$) can produce identical normal phenotypes.

  • Dominant phenotypes are observed in both homozygous dominant ($AA$) and heterozygous ($Aa$) states.

  • Recessive phenotypes are observed strictly in the homozygous recessive ($aa$) state.

  • Phenotypic expression is influenced by interactions between the genotype and the environment (including both the internal genetic background and external environmental factors, such as dietary protein intake in Phenylketonuria [PKU]).

• Monohybrid Cross Dynamics:

  • Consider a monohybrid cross between two heterozygous tall pea plants carrying tall ($H$) and short ($h$) alleles ($Hh \times Hh$):

  • Parent Gametes: Each parent produces $H$ and $h$ gametes in equal proportions ($\frac{1}{2}$ each).

  • Offspring Genotypes: $1\,HH : 2\,Hh : 1\,hh$ (Genotypic ratio $1:2:1$).

  • Offspring Phenotypes: $3 \text{ Tall} : 1 \text{ Short}$ (Phenotypic ratio $3:1$).

  • Recessive short plants ($hh$) occur with a probability of $\frac{1}{2} \times \frac{1}{2} = \frac{1}{4}$ ($25\%$), requiring both parents to contribute an $h$ allele.

Human Mendelian Traits & Pedigree Analysis

• Common Human Autosomal Mendelian Traits:

  • Mid-digital Hair: Dominant expression.

  • Tongue Rolling Ability: Dominant expression.

  • Widow's Peak Hairline: Dominant expression (straight hairline is recessive).

  • Unattached/Free Earlobes: Dominant expression (attached earlobes are recessive).

Dihybrid Crosses & Independent Assortment

• Dihybrid Cross Model ($AaDd \times AaDd$):

  • Analyzes the simultaneous inheritance of two independent, unlinked autosomal recessive traits.

  • Clinical Model: A cross between two individuals who are double heterozygotes (carriers) for two autosomal recessive conditions, such as Pigmentation ($A$ = normal, $a$ = albinism) and Hearing ($D$ = normal, $d$ = sensorineural deafness).

• Gamete Formation & Punnett Square Grid:

  • Each double heterozygous parent ($AaDd$) generates four distinct gamete types in equal frequencies ($\frac{1}{4}$ or $25\%$ each): $AD$, $Ad$, $aD$, and $ad$.

  • Combining these gametes in a $4 \times 4$ grid yields $16$ offspring combinations.

• Genotypic Frequencies ($9$ Distinct Genotypes):

  • $1\,AADD$ ($\frac{1}{16}$)

  • $2\,AADd$ ($\frac{2}{16} = \frac{1}{8}$)

  • $1\,AAdd$ ($\frac{1}{16}$)

  • $2\,AaDD$ ($\frac{2}{16} = \frac{1}{8}$)

  • $4\,AaDd$ ($\frac{4}{16} = \frac{1}{4}$)

  • $2\,Aadd$ ($\frac{2}{16} = \frac{1}{8}$)

  • $1\,aaDD$ ($\frac{1}{16}$)

  • $2\,aaDd$ ($\frac{2}{16} = \frac{1}{8}$)

  • $1\,aadd$ ($\frac{1}{16}$)

• Phenotypic Frequencies Classical $9:3:3:1$ Ratio:

  • $9/16$ Normal Pigment, Normal Hearing ($A\_D\_$)

  • $3/16$ Normal Pigment, Deaf ($A\_dd$)

  • $3/16$ Albinism, Normal Hearing ($aaD\_$)

  • $1/16$ Albinism, Deaf ($aadd$)

• Clinical Application Example (Dual Carrier Calculation):

  • Scenario: A couple where both partners are dual carriers for Cystic Fibrosis (CF) and Sickle Cell Disease (SCD).

  • Problem: Calculate the probability that they produce a child affected by EITHER Cystic Fibrosis OR Sickle Cell Disease, but NOT BOTH.

  • Calculation:

  • Total possible outcomes = $16$.

  • Phenotypes affected by CF only = $3/16$.

  • Phenotypes affected by SCD only = $3/16$.

  • Combined probability using the Addition Rule = $\frac{3}{16} + \frac{3}{16} = \frac{6}{16} = \frac{3}{8} = 0.375$ or $37.5\%$.

Probability Principles in Genetic Risk Assessment

• Fundamentals of Probability:

  • Probability quantifies the likelihood of a specific event occurring, expressed as a number between $0$ (impossible) and $1$ (certain).

  • The sum of probabilities for all mutually exclusive possible outcomes always equals $1.0$ ($100\%$).

• The Multiplication Rule (AND Rule):

  • Applicable when calculating the joint probability of two or more independent events occurring simultaneously.

  • $P(A \text{ and } B) = P(A) \times P(B)$

  • Example: The probability of tossing two heads consecutively on two coin flips is $\frac{1}{2} \times \frac{1}{2} = \frac{1}{4}$.

• The Addition Rule (OR Rule):

  • Applicable when calculating the combined probability of obtaining either one outcome OR another mutually exclusive outcome.

  • $P(A \text{ or } B) = P(A) + P(B)$

  • Example: The probability of flipping either two heads ($\frac{1}{4}$) OR two tails ($\frac{1}{4}$) in two coin tosses is $\frac{1}{4} + \frac{1}{4} = \frac{1}{2}$.

• Clinical Assessment Rule of Thumb:

  • When conducting genetic risk evaluations, always begin calculations with the most likely situation or most common cause before evaluating rare possibilities.

• Mathematical Conversion Procedure (Decimals to Fractions):

  • Step 1: Express the decimal over a denominator of $1$ ($\frac{\text{decimal}}{1}$).

  • Step 2: Multiply both numerator and denominator by $10^n$ ($n$ = number of digits after the decimal point).

  • Step 3: Reduce the fraction to its simplest form.

  • Example ($0.75$):

  • Step 1: $\frac{0.75}{1}$

  • Step 2: $\frac{0.75 \times 100}{1 \times 100} = \frac{75}{100}$

  • Step 3: $\frac{75 \div 5}{100 \div 5} = \frac{15}{20} \rightarrow \frac{15 \div 5}{20 \div 5} = \frac{3}{4}$

Population Genetics & The Hardy-Weinberg Principle

• Hardy-Weinberg Equilibrium Equations:

  • Relates gene (allele) frequencies to genotype frequencies in a stable population.

  • Let $p$ represent the frequency of the dominant allele ($A$ or $S$) and $q$ represent the frequency of the recessive allele ($a$ or $s$):

  • Allele Frequency Equation: $p + q = 1.0$

  • Genotype Frequency Equation: $p^2 + 2pq + q^2 = 1.0$

    • $p^2$ = Frequency of homozygous dominant genotype ($AA$ or $SS$)

    • $2pq$ = Frequency of heterozygous carrier genotype ($Aa$ or $Ss$)

    • $q^2$ = Frequency of homozygous recessive affected genotype ($aa$ or $ss$)

• Five Mandatory Population Assumptions:

  1. Exceptionally large population size (minimizes genetic drift).

  2. Complete absence of natural selection for or against any genotype.

  3. Random mating (panmixia) with respect to the gene locus of interest.

  4. Negligible rate of new gene mutations.

  5. Absence of gene flow (migration) into or out of the population.

Detailed Single-Gene Disorders & Clinical Risk Calculations

Sickle Cell Disease (SCD)

• Etiology & Disease Prevalence:

  • Autosomal recessive hemoglobinopathy resulting from homozygous mutation ($ss$ or $q^2$).

  • High prevalence in African American populations ($\approx \frac{1}{600}$ live births).

  • Extremely rare in Northern European populations.

• Pathophysiology & Clinical Manifestations:

  • Mutant hemoglobin causes round, flexible red blood cells to stiffen and assume a crescent/sickle shape.

  • Sickled cells lodge in microvasculature, producing vaso-occlusion and tissue ischemia.

  • Clinical Symptoms:

  • Recurrent severe pain episodes (affecting chest, back, legs, and arms).

  • Joint swelling and inflammation.

  • Painful swelling of hands and feet (dactylitis).

  • Chronic hemolytic anemia causing severe fatigue, paleness, and weakness.

  • Hyperbilirubinemia and jaundice (yellowing of skin and sclera).

• Hardy-Weinberg Carrier Frequency Derivation:

  • Given birth prevalence $q^2 = \frac{1}{600} \approx 0.001667$:

  • Recessive allele frequency ($q$): $q = \sqrt{\frac{1}{600}} \approx \frac{1}{24.5} \approx 0.04$

  • Dominant allele frequency ($p$): $p = 1.0 - q = 1.0 - 0.04 = 0.96$

  • Heterozygous carrier frequency ($2pq$): $2pq = 2 \times 0.96 \times 0.04 = 0.0768 \approx 0.08$ ($8\%$ or $\approx 1 \text{ in } 12$ African Americans).

  • Universal newborn screening mandates across all 50 US states systematically identify both sickle cell disease carriers and affected newborns.

Cystic Fibrosis (CF)

• Etiology & Population Frequencies:

  • Autosomal recessive multisystem disorder caused by mutations in the CFTR gene.

  • Frequency in European ancestry populations: $\approx \frac{1}{2,500}$ live births ($0.04\%$).

  • Frequency in general US population: $\approx 1 \text{ in } 3,300$.

  • Frequency in Asian ancestry populations: $\approx 1 \text{ in } 90,000$.

• Molecular Mechanism & Pathophysiology:

  • CFTR encodes an ATP-binding cassette (ABC) transporter functioning as a low-conductance Cl⁻ selective ion channel gated by ATP binding/hydrolysis at nucleotide-binding domains (NBDs) and regulated by phosphorylation of the regulatory domain.

  • Faulty epithelial chloride ion transport impairs water secretion, producing cell dehydration, thick viscous mucus accumulation, and hyper-saline ("salty") sweat.

• Multisystem Clinical Features:

  • Pulmonary & Pancreatic System: Recurrent endobronchial bacterial infections, progressive bronchiectasis, pancreatic exocrine insufficiency causing severe nutrient malabsorption and failure to thrive.

  • Gastrointestinal System: Chronic severe constipation, meconium ileus in neonates.

  • Genitourinary System (Biological Males): Congenital bilateral absence of the vas deferens (CBAVD), causing obstructive azoospermia and male infertility.

  • Prognosis & Survival: Historical median survival age was $31\,\text{years}$; recent updates report extended median survival to $36.9\,\text{years}$ or $47\,\text{years}$ depending on registry data, with modern targeted therapies significantly prolonging life expectancy. Mild phenotypes also exist.

• CFTR Mutation Classification Systems:

  • Over $2,000$ distinct mutations identified in CFTR.

  • Class I (Protein Production Mutations): No functional CFTR created due to nonsense, splice site mutations, or deletions (e.g., G542X, W1282X, R553X; present in $22\%$ of CF patients). Proposed subclassifications: Class 1A (no mRNA) and Class 1B (no protein). Therapy: Read-through compounds.

  • Class II (Protein Processing Mutations): CFTR is created but misfolds, preventing trafficking to the cell surface (e.g., F508del, N1303K, I507del; present in $88\%$ of CF patients). Therapy: Correctors (e.g., lumacaftor, tezacaftor).

  • Class III (Gating Mutations): CFTR reaches the cell surface, but the channel gate fails to open properly (e.g., G551D, S549N; present in $6\%$ of CF patients). Therapy: Potentiators (e.g., ivacaftor).

  • Class IV (Conduction Mutations): CFTR reaches the cell surface, but channel conductance/chloride transport is faulty (e.g., D1152H, R347P, R117H; present in $6\%$ of CF patients). Therapy: Potentiators (e.g., ivacaftor).

  • Class V (Insufficient Protein Mutations): Normal CFTR is produced and reaches the cell surface, but in reduced quantities (e.g., $3849+10\text{kbC}\rightarrow\text{T}$, $2789+5\text{G}\rightarrow\text{A}$, A455E; present in $5\%$ of CF patients). Therapy: Potentiators.

• Carrier Screening & Diagnostic Protocols:

  • Historical Standard (ACOG 2001): Targeted screening offered to couples with a family history of CF, partners of individuals with CF, and European or Ashkenazi Jewish couples.

  • Modern Standard: Universal newborn screening conducted in all 50 US states. Gene sequencing is increasingly used to identify rare CFTR sequence variants, avoiding low detection rates associated with targeted mutation panels.

• Hardy-Weinberg Calculation for European Populations:

  • Affected birth prevalence $q^2 = \frac{1}{2500} = 0.0004$

  • Recessive allele frequency $q = \sqrt{\frac{1}{2500}} = \frac{1}{50} = 0.02$

  • Dominant allele frequency $p = 1.0 - 0.02 = 0.98$

  • Heterozygous carrier frequency $2pq = 2 \times 0.98 \times 0.02 = 0.0392 \approx 0.04$ ($4\%$ or $\approx 1 \text{ in } 25$ Europeans).

Worked Clinical Risk Calculations

• Problem 1: European Couple with Unknown Genotypes

  • Question: What is the probability that a European couple of unknown genotypes will have a child with cystic fibrosis?

  • Calculation:

  • Probability father is carrier = $\frac{1}{25}$

  • Probability mother is carrier = $\frac{1}{25}$

  • Probability two carriers produce an affected child = $\frac{1}{4}$

  • Combined Probability = $\frac{1}{25} \times \frac{1}{25} \times \frac{1}{4} = \frac{1}{2500} = 0.0004$ or $0.04\%$.

• Problem 2: Known Carrier Partnered with European Individual of Unknown Genotype

  • Question: What is the probability that a man known to be a carrier of cystic fibrosis, and his wife of European descent and unknown genotype, will have a child with cystic fibrosis?

  • Calculation:

  • Probability father is carrier = $1$ (known obligate carrier)

  • Probability mother is carrier = $\frac{1}{25}$

  • Probability two carriers produce an affected child = $\frac{1}{4}$

  • Combined Probability = $1 \times \frac{1}{25} \times \frac{1}{4} = \frac{1}{100} = 0.01$ or $1\%$.

• Problem 3: Healthy Sibling of an Affected Individual

  • Question: What is the probability that the healthy sibling of a person with severe cystic fibrosis is a carrier of cystic fibrosis, assuming both parents are healthy?

  • Calculation:

  • Since both parents are unaffected but produced a child with severe CF ($aa$), both parents are obligate heterozygous carriers ($Aa \times Aa$).

  • Unconditional offspring genotypic distribution: 1\,AA : 2\,Aa : 1\,aa$.\n - Because the sibling is known to be healthy, the homozygous recessive (aa) genotype is excluded from the sample space.\n - Remaining possible genotypes in sample space = 3$($1\,AA$and$2\,Aa).\n - Conditional probability of being a carrier (Aa$) =$\frac{2}{3} \approx 66.7\%$or$0.667$$.